Esperion Therapeutics (ESPR) Shares Outstanding (2018 - 2025)
Historic Shares Outstanding for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to $205.4 million.
- Esperion Therapeutics' Shares Outstanding rose 511.14% to $205.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.4 million, marking a year-over-year increase of 511.14%. This contributed to the annual value of $195.9 million for FY2024, which is 6568.14% up from last year.
- As of Q3 2025, Esperion Therapeutics' Shares Outstanding stood at $205.4 million, which was up 511.14% from $200.2 million recorded in Q2 2025.
- Esperion Therapeutics' 5-year Shares Outstanding high stood at $205.4 million for Q3 2025, and its period low was $26.2 million during Q1 2021.
- For the 5-year period, Esperion Therapeutics' Shares Outstanding averaged around $116.1 million, with its median value being $100.9 million (2023).
- As far as peak fluctuations go, Esperion Therapeutics' Shares Outstanding crashed by 532.34% in 2021, and later surged by 16770.2% in 2022.
- Quarter analysis of 5 years shows Esperion Therapeutics' Shares Outstanding stood at $60.9 million in 2021, then increased by 22.49% to $74.6 million in 2022, then skyrocketed by 58.52% to $118.2 million in 2023, then skyrocketed by 65.68% to $195.9 million in 2024, then increased by 4.89% to $205.4 million in 2025.
- Its Shares Outstanding was $205.4 million in Q3 2025, compared to $200.2 million in Q2 2025 and $196.7 million in Q1 2025.